Cited by 151Tuberculosis Research and EpidemiologyBacterial Genetics and BiotechnologyInfectious Diseases and Tuberculosis

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Menaquinone synthesis is critical for maintaining mycobacterial viability during exponential growth and recovery from non‐replicating persistence

Open access

Dhiman, Rakesh K., Mahapatra, Sebabrata, Slayden, Richard A., Boyne, Melissa E., Lenaerts, Anne, Hinshaw, Jerald C., Angala, Shiva K., Chatterjee, Delphi, Biswas, Kallolmay, Narayanasamy, Prabagaran, Kurosu, Michio, Crick, Dean C.·2009·Molecular Microbiology

DOI 10.1111/j.1365-2958.2009.06625.xPMC PMC4747042

Open this paper in CoChat — free account

Abstract

Summary: Understanding the basis of bacterial persistence in latent infections is critical for eradication of tuberculosis. Analysis of Mycobacterium tuberculosis mRNA expression in an in vitro model of non‐replicating persistence indicated that the bacilli require electron transport chain components and ATP synthesis for survival. Additionally, low μM concentrations of aminoalkoxydiphenylmethane derivatives inhibited both the aerobic growth and survival of non‐replicating, persistent M. tuberculosis. Metabolic labelling studies and quantification of cellular menaquinone levels suggested that menaquinone synthesis, and consequently electron transport, is the target of the aminoalkoxydiphenylmethane derivatives. This hypothesis is strongly supported by the observations that treatment with these compounds inhibits oxygen consumption and that supplementation of growth medium with exogenous menaquinone rescued both growth and oxygen consumption of treated bacilli. In vitro assays indicate that the aminoalkoxydiphenylmethane derivatives specifically inhibit MenA, an enzyme involved in the synthesis of menaquinone. Thus, the results provide insight into the physiology of mycobacterial persistence and a basis for the development of novel drugs that enhance eradication of persistent bacilli and latent tuberculosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1111/j.1365-2958.2009.06625.x

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847
Multiple sequence alignment with hierarchical clustering.
Corpet, F. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.22.10881 · Cited by 5,575
Genes required for mycobacterial growth defined by high density mutagenesis
Sassetti, C. M., Boyd, D. H., & Rubin, E. J. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03425.x · Cited by 2,544
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W. H., Neefs, J.-M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M., Lee, E., et al. (2005) · Science · doi:10.1126/science.1106753 · Cited by 2,191 · cited 2×
“Because it has recently been shown that both the electron transport system and ATP synthesis are viable anti-TB drug targets (Andries et al., 2005; Weinstein et al., 2005) it was hypothesized that menaquinone synthesis could be critical for mycobacterial survival and the following studies were…”
Background
Distribution of isoprenoid quinone structural types in bacteria and their taxonomic implication
Collins, M. D., & Jones, D. A. (1981) · Microbiological Reviews · doi:10.1128/mr.45.2.316-354.1981 · Cited by 1,619
Escherichia coli and Salmonella.
Neidhart, F. C. (1996) · Cited by 1,577
Genetic requirements for mycobacterial survival during infection
Sassetti, C. M., & Rubin, E. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2134250100 · Cited by 1,327
An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence
Wayne, L. G., & Hayes, L. G. (1996) · Infection and Immunity · doi:10.1128/iai.64.6.2062-2069.1996 · Cited by 1,141
Inhibition of Respiration by Nitric Oxide Induces a Mycobacterium tuberculosis Dormancy Program
Voskuil, M. I., Schnappinger, D., Visconti, K. C., Harrell, M. I., Dolganov, G., Sherman, D. R., & Schoolnik, G. K. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030205 · Cited by 975

Show all 49 references

Research works printed but not linked: 3

10.1128/MMBR.45.2.316-354.1981 · DOI
Meganathan R., 1996, Escherichia coli and Salmonella, 642
Minnikin D.E., 1982, The Biology of Mycobacteria., 95

Sorted by citations

Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections
Hurdle, J. G., O’Neill, A. J., Chopra, I., & Lee, R. E., Jr. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2474 · Cited by 890
Molecular mechanisms of membrane targeting antibiotics
Epand, R. M., Walker, C., Epand, R. F., & Magarvey, N. A. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.10.018 · Cited by 701
Targeting Persisters for Tuberculosis Control
Zhang, Y., Yew, W. W., & Barer, M. R. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06288-11 · Cited by 276
The Mycobacterial Cell Envelope--LipidsPreprint
Jackson, M. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a021105 · Cited by 282
Latent Tuberculosis Infection: Myths, Models, and Molecular Mechanisms
Dutta, N. K., & Karakousis, P. C. (2014) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00010-14 · Cited by 256
Absolute Proteome Composition and Dynamics during Dormancy and Resuscitation of Mycobacterium tuberculosis
Schubert, O. T., Ludwig, C., Kogadeeva, M., Zimmermann, M., Rosenberger, G., Gengenbacher, M., Gillet, L. C., Collins, B. C., Röst, H. L., Kaufmann, S. H. E., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.06.001 · Cited by 211
Multitarget Drug Discovery for Tuberculosis and Other Infectious Diseases
Li, K., Schurig-Briccio, L. A., Feng, X., Upadhyay, A., Pujari, V., Lechartier, B., Fontes, F. L., Yang, H., Rao, G., Zhu, W., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500131s · Cited by 224
Self-citation
Energetics of Respiration and Oxidative Phosphorylation in Mycobacteria
Cook, G. M., Hards, K., Vilchèze, C., Hartman, T., & Berney, M. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.mgm2-0015-2013 · Cited by 212
“Several new antitubercular compounds have been reported that target oxidative phosphorylation in mycobacteria (12, 109, 110).”
Background
Novel Insights into the Mechanism of Inhibition of MmpL3, a Target of Multiple Pharmacophores in Mycobacterium tuberculosis
Li, W., Upadhyay, A., Fontes, F. L., North, E. J., Wang, Y., Crans, D. C., Grzegorzewicz, A. E., Jones, V., Franzblau, S. G., Lee, R. E., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03229-14 · Cited by 202
Self-citation
The Tuberculosis Drug Discovery and Development Pipeline and Emerging Drug TargetsPreprint
Mdluli, K. E., Kaneko, T., & Upton, A. M. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a021154 · Cited by 185
Vitamin K2 in Electron Transport System: Are Enzymes Involved in Vitamin K2 Biosynthesis Promising Drug Targets?
Kurosu, M., & Begari, E. (2010) · Molecules · doi:10.3390/molecules15031531 · Cited by 166
Self-citation
Mode of Action of Clofazimine and Combination Therapy with Benzothiazinones against Mycobacterium tuberculosis
Lechartier, B., & Cole, S. T. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00395-15 · Cited by 158
Energy Metabolism and Drug Efflux in Mycobacterium tuberculosis
Black, P. A., Warren, R. M., Louw, G., van Helden, P. D., Victor, T. C., & Kana, B. D. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02293-13 · Cited by 152
Essential roles of methionine and S -adenosylmethionine in the autarkic lifestyle of Mycobacterium tuberculosis
Berney, M., Berney‐Meyer, L., Wong, K., Chen, B., Chen, M., Kim, J., Wang, J., Harris, D. E., Parkhill, J., Chan, J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1513033112 · Cited by 139
Novel targets to develop new antibacterial agents and novel alternatives to antibacterial agents
Belete, T. M. (2019) · Human Microbiome Journal · doi:10.1016/j.humic.2019.01.001 · Cited by 139
Oxidative Phosphorylation as a Target Space for Tuberculosis: Success, Caution, and Future Directions
Cook, G. M., Hards, K., Dunn, E. A., Heikal, A., Nakatani, Y., Greening, C., Crick, D. C., Fontes, F. L., Pethe, K., Hasenoehrl, E., et al. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.tbtb2-0014-2016 · Cited by 131
Self-citation
Discovery of Selective Menaquinone Biosynthesis Inhibitors against Mycobacterium tuberculosis
Debnath, J., Siricilla, S., Wan, B., Crick, D. C., Lenaerts, A. J. M., Franzblau, S. G., & Kurosu, M. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201608g · Cited by 128
Self-citation
Energetics of Pathogenic Bacteria and Opportunities for Drug Development
Cook, G. M., Greening, C., Hards, K., & Berney, M. (2014) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/bs.ampbs.2014.08.001 · Cited by 129
Bringing Bioactive Compounds into Membranes: The UbiA Superfamily of Intramembrane Aromatic Prenyltransferases
Li, W. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.01.007 · Cited by 114
Genetics of Capsular Polysaccharides and Cell Envelope (Glyco)lipids
Daffé, M., Crick, D. C., & Jackson, M. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.mgm2-0021-2013 · Cited by 105
Self-citation
Targeting bacterial energetics to produce new antimicrobials
Hards, K., & Cook, G. M. (2017) · Drug Resistance Updates · doi:10.1016/j.drup.2017.11.001 · Cited by 102
Biochemical and structural characterization of CYP124: A methyl-branched lipid ω-hydroxylase from Mycobacterium tuberculosis
Johnston, J. B., Kells, P. M., Podust, L. M., & de Montellano, P. R. O. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907398106 · Cited by 97
DosS Responds to a Reduced Electron Transport System To Induce the Mycobacterium tuberculosis DosR Regulon
Honaker, R. W., Dhiman, R. K., Narayanasamy, P., Crick, D. C., & Voskuil, M. I. (2010) · Journal of Bacteriology · doi:10.1128/jb.00978-10 · Cited by 87
Self-citation
A Novel Small-Molecule Inhibitor of the Mycobacterium tuberculosis Demethylmenaquinone Methyltransferase MenG Is Bactericidal to Both Growing and Nutritionally Deprived Persister Cells
Sukheja, P., Kumar, P., Mittal, N., Li, S.-G., Singleton, E., Russo, R., Perryman, A. L., Shrestha, R., Awasthi, D., Husain, S., et al. (2017) · mBio · doi:10.1128/mbio.02022-16 · Cited by 86
The bacillary and macrophage response to hypoxia in tuberculosis and the consequences for T cell antigen recognition
Prosser, G. A., Brandenburg, J., Reiling, N., Barry, C. E., Wilkinson, R. J., & Wilkinson, K. A. (2016) · Microbes and Infection · doi:10.1016/j.micinf.2016.10.001 · Cited by 86
Genome-based exploration of the specialized metabolic capacities of the genus Rhodococcus
Ceniceros, A., Dijkhuizen, L., Petrusma, M., & Medema, M. H. (2017) · BMC Genomics · doi:10.1186/s12864-017-3966-1 · Cited by 80
Adenylating Enzymes in Mycobacterium tuberculosis as Drug Targets
Duckworth, B. P., Nelson, K. M., & Aldrich, C. C. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612799984571 · Cited by 76
Partial Saturation of Menaquinone in Mycobacterium tuberculosis: Function and Essentiality of a Novel Reductase, MenJ
Upadhyay, A., Fontes, F. L., Juarrero, M. G., McNeil, M., Crans, D. C., Jackson, M., & Crick, D. C. (2015) · ACS Central Science · doi:10.1021/acscentsci.5b00212 · Cited by 73
Self-citation
Bioenergetics of Mycobacterium: An Emerging Landscape for Drug Discovery
Iqbal, I., Bajeli, S., Akela, A. K., & Kumar, A. (2018) · Pathogens · doi:10.3390/pathogens7010024 · Cited by 66
Identification of a Hotdog Fold Thioesterase Involved in the Biosynthesis of Menaquinone in Escherichia coli
Chen, M., Ma, X., Chen, X., Jiang, M., Song, H., & Guo, Z. (2013) · Journal of Bacteriology · doi:10.1128/jb.00141-13 · Cited by 60
Advances in menaquinone biosynthesis: sublocalisation and allosteric regulation
Johnston, J. M., & Bulloch, E. M. M. (2020) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2020.05.005 · Cited by 59
Advances in MRSA drug discovery: where are we and where do we need to be?
Kurosu, M., Siricilla, S., & Mitachi, K. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.807246 · Cited by 56
Self-citation
Bioenergetic Inhibitors: Antibiotic Efficacy and Mechanisms of Action in Mycobacterium tuberculosis
Hasenoehrl, E., Wiggins, T. J., & Berney, M. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.611683 · Cited by 54
Intraerythrocytic stages of Plasmodium falciparum biosynthesize menaquinone
Tonhosolo, R., Gabriel, H. B., Matsumura, M. Y., Cabral, F. J., Yamamoto, M. M., D’Alexandri, F. L., Sussmann, R. A. C., Belmonte, R. C., Peres, V. J., Crick, D. C., et al. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.10.055 · Cited by 55
Self-citation
Oxidative Phosphorylation—an Update on a New, Essential Target Space for Drug Discovery in Mycobacterium tuberculosis
Foo, C. S.-Y., Pethe, K., & Lupien, A. (2020) · Applied Sciences · doi:10.3390/app10072339 · Cited by 55
Accumulation of heptaprenyl diphosphate sensitizes Bacillus subtilis to bacitracin: Implications for the mechanism of resistance mediated by the BceAB transporter
Kingston, A. W., Zhao, H., Cook, G. M., & Helmann, J. (2014) · Molecular Microbiology · doi:10.1111/mmi.12637 · Cited by 51
Tuberculosis drug discovery and emerging targets
Mdluli, K. E., Kaneko, T., & Upton, A. M. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12459 · Cited by 48
Identification of arylamine N-acetyltransferase inhibitors as an approach towards novel anti-tuberculars
Westwood, I. M., Bhakta, S., Russell, A. J., Fullam, E., Anderton, M. C., Kawamura, A., Mulvaney, A. W., Vickers, R. J., Bhowruth, V., Besra, G. S., et al. (2010) · Protein & Cell · doi:10.1007/s13238-010-0006-1 · Cited by 47
Menaquinone as a potential target of antibacterial agents
Paudel, A., Hamamoto, H., Panthee, S., & Sekimizu, K. (2016) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2016.01041 · Cited by 47
5′-Methylthioadenosine Nucleosidase Is Implicated in Playing a Key Role in a Modified Futalosine Pathway for Menaquinone Biosynthesis in Campylobacter jejuni
Li, X., Apel, D., Gaynor, E. C., & Tanner, M. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.229781 · Cited by 47
Phylogeny Trumps Chemotaxonomy: A Case Study Involving Turicella otitidis
Baek, I., Kim, M., Lee, I., Na, S.-I., Goodfellow, M., & Chun, J. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00834 · Cited by 45
Two uptake hydrogenases differentially interact with the aerobic respiratory chain during mycobacterial growth and persistence
Cordero, P. R. F., Grinter, R., Hards, K., Cryle, M. J., Warr, C. G., Cook, G. M., & Greening, C. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011076 · Cited by 44
Inhibition of Mycobacterial Growth by Plumbagin Derivatives
Mathew, R., Kruthiventi, A. K., Prasad, J. V., Kumar, S. P., Srinu, G., & Chatterji, D. (2010) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2010.00987.x · Cited by 45
CoA Adducts of 4-Oxo-4-phenylbut-2-enoates: Inhibitors of MenB from the M. tuberculosis Menaquinone Biosynthesis Pathway
Li, X., Liu, N., Zhang, H., Knudson, S. E., Li, H., Lai, C., Simmerling, C. L., Slayden, R. A., & Tonge, P. J. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200141e · Cited by 41
Self-citation
Succinylphosphonate Esters Are Competitive Inhibitors of MenD That Show Active-Site Discrimination between Homologous α-Ketoglutarate-Decarboxylating Enzymes
Fang, M., Toogood, R. D., Macova, A., Ho, K., Franzblau, S. G., McNeil, M., Sanders, D. A. R., & Palmer, D. R. J. (2010) · Biochemistry · doi:10.1021/bi901432d · Cited by 40
The membrane as a target for controlling hypervirulent Clostridium difficile infections
Wu, X., Cherian, P., Lee, R. E., Jr., & Hurdle, J. G. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks493 · Cited by 38
Primary transcriptomes of Mycobacterium avium subsp. paratuberculosis reveal proprietary pathways in tissue and macrophages
Janagama, H. K., Lamont, E. A., George, S. D., Bannantine, J. P., Xu, W. W., Tu, Z. J., Wells, S. J., Schefers, J. M., & Sreevatsan, S. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-561 · Cited by 37
RepTB: a gene ontology based drug repurposing approach for tuberculosis
Passi, A., Rajput, N. K., Wild, D. J., & Bhardwaj, A. (2018) · Journal of Cheminformatics · doi:10.1186/s13321-018-0276-9 · Cited by 36
2-aminoimidazoles collapse mycobacterial proton motive force and block the electron transport chain
Jeon, A. B., Ackart, D. F., Li, W., Jackson, M., Melander, R. J., Melander, C., Abramovitch, R. B., Chicco, A. J., Basaraba, R. J., & Obregón‐Henao, A. (2019) · Scientific Reports · doi:10.1038/s41598-018-38064-7 · Cited by 35
Mycobacterium Lysine ε-aminotransferase is a novel alarmone metabolism related persister gene via dysregulating the intracellular amino acid level
Duan, X., Li, Y., Du, Q., Huang, Q., Guo, S., Xu, M., Lin, Y., Liu, Z., & Xie, J. (2016) · Scientific Reports · doi:10.1038/srep19695 · Cited by 37
Small organic molecules targeting the energy metabolism of Mycobacterium tuberculosis
Urban, M., Šlachtová, V., & Brulíková, L. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.113139 · Cited by 34
S -Adenosylmethionine–responsive cystathionine β-synthase modulates sulfur metabolism and redox balance in Mycobacterium tuberculosis
Bandyopadhyay, P., Pramanick, I., Biswas, R., Sabarinath, P. S., Sreedharan, S., Singh, S. T., Rajmani, R. S., Laxman, S., Dutta, S., & Singh, A. (2022) · Science Advances · doi:10.1126/sciadv.abo0097 · Cited by 34
Mechanism of MenE Inhibition by Acyl-Adenylate Analogues and Discovery of Novel Antibacterial Agents
Matarlo, J. S., Evans, C. E. B., Sharma, I., Lavaud, L. J., Ngo, S. C., Shek, R., Rajashankar, K. R., French, J. B., Tan, D. S., & Tonge, P. J. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00966 · Cited by 33
Microbial Cytochromes P450
McLean, K. J., Leys, D., & Munro, A. W. (2015) · Springer eBooks · doi:10.1007/978-3-319-12108-6_6 · Cited by 36
Structure of mycobacterial respiratory complex I
Liang, Y., Plourde, A., Bueler, S. A., Liu, J., Brzezinski, P., Vahidi, S., & Rubinstein, J. L. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2214949120 · Cited by 31
Discovery of Bicyclic Inhibitors Against Menaquinone Biosynthesis
Choi, S., Larson, M. A., Hinrichs, S. H., Bartling, A. M., Frandsen, J. R., & Narayanasamy, P. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.168 · Cited by 31
Self-citation
Gene Regulatory Mechanism of Mycobacterium Tuberculosis during Dormancy
Liu, Y., Li, H., Dai, D., He, J., & Liang, Z. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46060348 · Cited by 29
Gene expression profiling of Mycobacterium avium subsp. paratuberculosis in simulated multi-stress conditions and within THP-1 cells reveals a new kind of interactive intramacrophage behaviour
Cossu, A., Sechi, L. A., Zanetti, S., & Rosu, V. (2012) · BMC Microbiology · doi:10.1186/1471-2180-12-87 · Cited by 30
Drug targets in dormant Mycobacterium tuberculosis: can the conquest against tuberculosis become a reality?
Gupta, V. K., Kumar, M. M., Singh, D. K., Bisht, D., & Sharma, S. (2017) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2017.1377346 · Cited by 29
Allosteric regulation of menaquinone (vitamin K2) biosynthesis in the human pathogen Mycobacterium tuberculosis
Bashiri, G., Nigon, L. V., Jirgis, E. N. M., Ho, N. A. T., Stanborough, T., Dawes, S. S., Baker, E. N., Bulloch, E. M. M., & Johnston, J. M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012158 · Cited by 29
Mycobacterial MenJ: An Oxidoreductase Involved in Menaquinone Biosynthesis
Upadhyay, A., Kumar, S., Rooker, S. A., Koehn, J. T., Crans, D. C., McNeil, M., Lott, J. S., & Crick, D. C. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00402 · Cited by 29
Self-citation
Novel long-chain compounds with both immunomodulatory and MenA inhibitory activities against Staphylococcus aureus and its biofilm
Choi, S., Frandsen, J. R., & Narayanasamy, P. (2017) · Scientific Reports · doi:10.1038/srep40077 · Cited by 28
Self-citation
Discovery of Lipophilic Bisphosphonates That Target Bacterial Cell Wall and Quinone Biosynthesis
Malwal, S. R., Chen, L., Hicks, H., Qu, F., Liu, W., Shillo, A., Law, W. X., Zhang, J., Chandnani, N., Han, X., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01878 · Cited by 26
Characterization of MenA (isoprenyl diphosphate:1,4-dihydroxy-2-naphthoate isoprenyltransferase) from Mycobacterium tuberculosis
Dhiman, R. K., Pujari, V., Kincaid, J. M., Ikeh, M. A. C., Parish, T., & Crick, D. C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214958 · Cited by 26
Self-citation
Novel targets and inhibitors of the Mycobacterium tuberculosis cytochrome bd oxidase to foster anti-tuberculosis drug discovery
Harikishore, A., Mathiyazakan, V., Pethe, K., & Grüber, G. (2023) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2224553 · Cited by 26
Metabolic profiling of dormant Mycolicibacterium smegmatis cells’ reactivation reveals a gradual assembly of metabolic processes
Nikitushkin, V. D., Trenkamp, S., Demina, G. R., Shleeva, M. O., & Kaprelyants, A. S. (2020) · Metabolomics · doi:10.1007/s11306-020-1645-8 · Cited by 27
Energetics of Respiration and Oxidative Phosphorylation in Mycobacteria
Cook, G. M., Hards, K., Vilchèze, C., Hartman, T. E., & Berney, M. (2015) · ASM Press eBooks · doi:10.1128/9781555818845.ch20 · Cited by 23
Biosynthesis and Regulation of Sulfomenaquinone, a Metabolite Associated with Virulence in Mycobacterium tuberculosis
Sogi, K. M., Holsclaw, C. M., Fragiadakis, G. K., Nomura, D. K., Leary, J. A., & Bertozzi, C. R. (2016) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6b00106 · Cited by 22
Using Substrate Analogues To Probe the Kinetic Mechanism and Active Site of Escherichia coli MenD
Fang, M., Macova, A., Hanson, K., Kos, J., & Palmer, D. R. J. (2011) · Biochemistry · doi:10.1021/bi201202n · Cited by 22
Structural Views along the Mycobacterium tuberculosis MenD Reaction Pathway Illuminate Key Aspects of Thiamin Diphosphate-Dependent Enzyme Mechanisms
Jirgis, E. N. M., Bashiri, G., Bulloch, E. M. M., Johnston, J. M., & Baker, E. N. (2016) · Structure · doi:10.1016/j.str.2016.04.018 · Cited by 22
A dual-targeting succinate dehydrogenase and F1Fo-ATP synthase inhibitor rapidly sterilizes replicating and non-replicating Mycobacterium tuberculosis
Adolph, C., Cheung, C., McNeil, M. B., Jowsey, W. J., Williams, Z. C., Hards, K., Harold, L. K., Aboelela, A., Bujaroski, R. S., Buckley, B. J., et al. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.12.002 · Cited by 21
Mycoketide: A CD1c-Presented Antigen with Important Implications in Mycobacterial Infection
Matsunaga, I., & Sugita, M. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/981821 · Cited by 21
Demethylmenaquinone Methyl Transferase Is a Membrane Domain-Associated Protein Essential for Menaquinone Homeostasis in Mycobacterium smegmatis
Puffal, J., Mayfield, J. A., Moody, D. B., & Morita, Y. S. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03145 · Cited by 23
ATP synthesis driven by atmospheric hydrogen concentrations
Soom, S., Moning, S. U., Cook, G. M., Lingford, J. P., Kropp, A., Tran, S. L., Grinter, R., Greening, C., & von Ballmoos, C. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2506353122 · Cited by 20
Genetic Approaches to Facilitate Antibacterial Drug DevelopmentPreprint
Schnappinger, D. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a021139 · Cited by 21
Current possibilities and unresolved issues of drug target validation inMycobacterium tuberculosis
Sharma, U. K. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.626763 · Cited by 19
Electron Transport Chain Is Biochemically Linked to Pilus Assembly Required for Polymicrobial Interactions and Biofilm Formation in the Gram-Positive Actinobacterium Actinomyces oris
Sanchez, B. C., Chang, C., Wu, C., Tran, B., & Ton‐That, H. (2017) · mBio · doi:10.1128/mbio.00399-17 · Cited by 19
New Structural Templates for Clinically Validated and Novel Targets in Antimicrobial Drug Research and Development
Klahn, P., & Brönstrup, M. (2016) · Current topics in microbiology and immunology · doi:10.1007/82_2016_501 · Cited by 18
An update on ATP synthase inhibitors: A unique target for drug development in M. tuberculosis
Kelam, L. M., Wani, M. A., & Dhaked, D. K. (2023) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2023.04.009 · Cited by 17
Tuberculosis: current scenario, drug targets, and future prospects
Bose, P., Harit, A. K., Das, R., Sau, S., Iyer, A. K., & Kashaw, S. K. (2021) · Medicinal Chemistry Research · doi:10.1007/s00044-020-02691-5 · Cited by 18
Unveiling the regulatory mechanism of poly-γ-glutamic acid on soil characteristics under drought stress through integrated metagenomics and metabolomics analysis
Hong, L., Li, W., Fanglan, G., Li, J., Shiheng, T., Yang, H., Yao, R., XinYue, G., & Can, Y. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1387223 · Cited by 15
Oxidative Phosphorylation as a Target Space for Tuberculosis: Success, Caution, and Future Directions
Cook, G. M., Hards, K., Dunn, E. A., Heikal, A., Nakatani, Y., Greening, C., Crick, D. C., Fontes, F. L., Pethe, K., Hasenoehrl, E., et al. (2017) · ASM Press eBooks · doi:10.1128/9781555819569.ch14 · Cited by 15
Self-citation
Structural and functional analysis of Rv0554 fromMycobacterium tuberculosis: testing a putative role in menaquinone biosynthesis
Johnston, J. M., Jiang, M., Guo, Z., & Baker, E. N. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910025771 · Cited by 14
Uncovering interactions between mycobacterial respiratory complexes to target drug-resistant Mycobacterium tuberculosis
McNeil, M. B., Cheung, C., Waller, N. J. E., Adolph, C., Chapman, C. L., Seeto, N. E. J., Jowsey, W. J., Li, Z., Hameed, H. M. A., Zhang, T., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.980844 · Cited by 12
Unraveling bacterial stress responses: implications for next-generation antimicrobial solutions
Avcı, F. G. (2024) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-024-04090-z · Cited by 11
Methods for Structural and Functional Analyses of Intramembrane Prenyltransferases in the UbiA Superfamily
Yang, Y., Ke, N., Liu, S., & Li, W. (2016) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2016.10.032 · Cited by 12
QcrB inhibition as a potential approach for the treatment of tuberculosis: A review of recent developments, patents, and future directions
Imran, M., Abida, Alotaibi, N., Thabet, H. K., Alruwaili, J. A., Asdaq, S. M. B., Eltaib, L., Alshehri, A., Alsaiari, A. A., Almehmadi, M. M., et al. (2023) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2023.04.011 · Cited by 12
In Vitro and In Vivo Antimicrobial Activity of an Oxidative Stress-Mediated Bicyclic Menaquinone Biosynthesis Inhibitor against MRSA
Choi, S., & Narayanasamy, P. (2023) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00319 · Cited by 11
Self-citation
Two active site arginines are critical determinants of substrate binding and catalysis in MenD: a thiamine-dependent enzyme in menaquinone biosynthesis
Qin, M., Song, H., Dai, X., Chen, Y., & Guo, Z. (2018) · Biochemical Journal · doi:10.1042/bcj20180548 · Cited by 11
Stabilization of the Second Oxyanion Intermediate by 1,4-Dihydroxy-2-naphthoyl-Coenzyme A Synthase of the Menaquinone Pathway: Spectroscopic Evidence of the Involvement of a Conserved Aspartic Acid
Chen, M., Jiang, M., Sun, Y., Guo, Z., & Guo, Z. (2011) · Biochemistry · doi:10.1021/bi200376x · Cited by 11
Metabolite analysis of Mycobacterium species under aerobic and hypoxic conditions reveals common metabolic traits
Drapal, M., Wheeler, P. R., & Fraser, P. D. (2016) · Microbiology · doi:10.1099/mic.0.000325 · Cited by 11
Crystal Structures of E. coli Native MenH and Two Active Site Mutants
Johnston, J. M., Jiang, M., Guo, Z., & Baker, E. N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061325 · Cited by 11
The application of metabolite profiling to Mycobacterium spp.: Determination of metabolite changes associated with growth
Drapal, M., Pérez-Fons, L., Wheeler, P. R., & Fraser, P. D. (2014) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2014.07.037 · Cited by 12
Metabolite Profiling: A Tool for the Biochemical Characterisation of Mycobacterium sp.
Drapal, M., & Fraser, P. D. (2019) · Microorganisms · doi:10.3390/microorganisms7050148 · Cited by 10
Inhibitors of enzymes in the electron transport chain of Mycobacterium tuberculosis
Thompson, A. M., & Denny, W. A. (2019) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2019.05.001 · Cited by 11
Key Targets and Relevant Inhibitors for the Drug Discovery of Tuberculosis
Xiong, X., Xu, Z., Yang, Z., Liu, Y., Wang, D., Dong, M., Parker, E. J., & Zhu, W. (2013) · Current Drug Targets · doi:10.2174/1389450111314060009 · Cited by 11
Comparative Analysis, Structural Insights, and Substrate/Drug Interaction of CYP128A1 in Mycobacterium tuberculosis
Ngcobo, N. S., Chiliza, Z. E., Chen, W., Yu, J., Nelson, D. R., Tuszyński, J. A., Preto, J., & Syed, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144816 · Cited by 9
The Role of Amino Acid Substitution in HepT Toward Menaquinone Isoprenoid Chain Length Definition and Lysocin E Sensitivity in Staphylococcus aureus
Panthee, S., Paudel, A., Hamamoto, H., Uhlemann, A., & Sekimizu, K. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.02076 · Cited by 9
Impact of Target-Based Drug Design in Anti-bacterial Drug Discovery for the Treatment of Tuberculosis
Pushkaran, A. C., Biswas, R., & Mohan, C. G. (2019) · Challenges and advances in computational chemistry and physics · doi:10.1007/978-3-030-05282-9_10 · Cited by 9
Mycobacterium bovis frd operon phase variation hijacks succinate signaling to drive immunometabolic rewiring and pathogenicity
Dong, Y., Ge, X., Guo, Q., Ou, X., Liu, C., Wang, Y., Liu, Z., Yue, R., Fan, W., Zhao, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61824-9 · Cited by 8

Authors: Dhiman, R. K., Mahapatra, S., Slayden, R. A., Boyne, M. E., Lenaerts, A., Hinshaw, J. C., Angala, S. K., Chatterjee, D., Biswas, K., Narayanasamy, P., Kurosu, M., & Crick, D. C.
Affiliations: Colorado State University (US)
University of Utah (US)
Corresponding author: Crick, Dean C.
ORCID: Slayden, Richard A.
Chatterjee, Delphi
Biswas, Kallolmay
Narayanasamy, Prabagaran
Kurosu, Michio
Crick, Dean C.
Venue: Molecular Microbiology
Publisher: Wiley
Published: 2009-03-19
Volume: 72
Issue: 1
Pages: 85-97
ISSN: 0950-382X (ISSN-L)
1365-2958
DOI: 10.1111/j.1365-2958.2009.06625.x
PMC: PMC4747042
OpenAlex: W2152545013
Cited by: 146
References: 49
Citations by year: 2026: 5 · 2025: 5 · 2024: 7 · 2023: 10 · 2022: 6 · 2021: 6 · 2020: 11 · 2019: 11 · 2018: 7 · 2017: 11 · 2016: 10 · 2015: 12 · 2014: 14 · 2013: 5 · 2012: 7
FWCI: 5.98
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Molecular Microbiology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
National Institute of Allergy and Infectious Diseases (R56AI049151, R01AI055298, AI049151, AI-06357, P01AI057836, R01AI049151, AI055298, AI057836)
Topics: Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
Keywords: Mycobacterium tuberculosis, non-replicating persistence, latent tuberculosis infection, Middle East and North Africa, electron transport chain, oxygen consumption, bacterial persistence, tuberculosis drug development
MeSH terms: Adenosine Triphosphate, Mycobacterium tuberculosis, Oxygen Consumption, RNA, Bacterial, RNA, Messenger, Gene Expression Regulation, Bacterial, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Vitamin K 2, Electron Transport Chain Complex Proteins, Microbial Viability

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Menaquinone synthesis is critical for maintaining mycobacterial viability during exponential growth and recovery from non‐replicating persistence

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks